Search

The Molecular Microbiology Facility is a centralized, comprehensive facility for microbiota research. We provide academic, government and industry researchers with innovative, timely and reliable microbiome sample processing through our facility and coordinate with other cores within MSKCC to guarantee project completion and high-quality sequencing data. We offer professional expertise in microbiome methodologies and sampling strategies. The MMF implements stringent quality control standards to ensure consistent, valid services for investigators using the shared resource. The Facility is designed to enable and optimize diverse microbiota samples to research the complex ecological community of bacteria, fungi, viruses, and other organisms and explore ways in which the microbes influence many disease outcomes. We combine innovation and technology to investigate the host-microbiota in modulating cancer.

… Project Consultation We provide consultation on all aspects of study design and sample collection. We also foster informal discussions of microbiome investigators from varied backgrounds to enhance research studies at MSKCC. Our interdisciplinary group ranges from immunologists, infectious disease experts

… Charles L. Sawyers, MD, of Memorial Sloan Kettering Cancer Center Elected to the National Academy of Medicine Council Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling A New Approach in Prostate Cancer: Targeting the Cells Surrounding the Tumor MSK Experts Featured at the

Lonny Yarmus, DO, MBA, has been appointed Head of the Division of Subspecialty Medicine in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). A physician-scientist and internationally recognized leader in interventional pulmonology and procedural innovation, Dr. Yarmus is widely known for his expertise in minimally invasive diagnostics and therapeutics, outcomes research, and multidisciplinary program development.

… Tuesday, March 10, 2026 Lonny Yarmus, DO, MBA , has been appointed Head of the Division of Subspecialty Medicine in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). A physician-scientist and internationally recognized leader in interventional pulmonology and procedural innovation

… Intensivist Job Title Director, Critical Care Center; Chief, Critical Care Medicine Service; Medical Director, Respiratory Therapy Since joining the staff in 1999, I have served as Chief of the Critical Care Medicine Service and Medical Director of Respiratory Therapy. I am also Director of MSK’s Critical

… Intensivist Job Title Director, Centro de Medicina Intensiva; Jefe del Servicio de Medicina Intensiva; Director médico, Terapia respiratoria Desde que me incorporé al personal en 1999, me he desempeñado como jefe del Servicio de Medicina Intensiva y director médico de Terapia respiratoria. Además, soy

You may experience changes in your sexual health related to cancer and its treatments. Our experts — including doctors, social workers, and psychologists — provide personalized care to address your concerns.

… Cancer and its treatments can have an impact on your sexual health, whether you are a man or a woman. These changes can affect people physically and emotionally, decreasing interest in sexual activity as well as self-confidence. To help you take action and address sexual health issues related to cancer

Experts at Memorial Sloan Kettering Cancer Center (MSK) have identified genome doubling in cancer and have correlated it to a worse prognosis across cancer types. Using MSK-IMPACT™ to analyze matched tumor and normal DNA, MSK researchers were able to identify an abnormality in tumors known as genome doubling. This doubling occurs in 28 percent of all cancers and could have significant implications for treatment options in the future.

… Monday, July 16, 2018 Bottom Line: Experts at Memorial Sloan Kettering Cancer Center (MSK) have identified genome doubling in cancer and have correlated it to a worse prognosis across cancer types. Using MSK-IMPACT™ to analyze matched tumor and normal DNA, MSK researchers were able to identify an abnormality

Physician-scientist Karuna Ganesh studies stem cell plasticity in metastasis, therapy resistance and tissue regeneration.

… Metastasis causes >90% of cancer death.  The emergence, persistence, therapy resistance and lethality of metastatic cancer is driven by dynamic and tenacious metastasis stem cells (MetScs). The Ganesh lab focuses on understanding the molecular mechanisms that underlie the emergence of regenerative plasticity

… Tea will be served at 3:45 p.m. , immediately preceding the seminar. Audience This seminar is open to the research community. Location Memorial Sloan Kettering Cancer Center Rockefeller Research Laboratories 430 East 67th Street Room RRL-116 New York, NY 10065 Speaker(s) van Rechem Capucine, Ph.D. Assistant

The Functional Genomics Initiative is a powerful and unique engine for scientific discoveries at the interface between mechanistic biology and clinical research.

… Analyzing the genes and functional pathways of mutations that play a role in cancer provides novel insights into the biology of normal cells as well as the biological properties of tumors during their formation, spread, response to therapy, and relapse. History provides abundant precedent that advances